These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: 13,14-Dihydro-15-keto-prostaglandin F2 alpha in patients with urogenital tumors.
    Author: Dunzendorfer U, Zahradnik HP, Gerster K.
    Journal: Urol Int; 1980; 35(3):171-5. PubMed ID: 6155727.
    Abstract:
    13,14-Dihydro-15-keto-prostaglandin F2 alpha (13,14-DHK-PGF2 alpha) represents a stable product of degradation after pulmonary flow and it is shown to be reliably measured by radioimmunoassay. In patients with urogenital tumors, serum levels of 13,14-DHK-PGF2 alpha are distinctly elevated when compared to a control group. The rate of synthesis of this compound in urogenital tumors, however, appears to be different.
    [Abstract] [Full Text] [Related] [New Search]